Blog - Amiko
1815
page-template,page-template-blog-large-image,page-template-blog-large-image-php,page,page-id-1815,page-parent,ajax_fade,page_not_loaded,,qode-theme-ver-13.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.5,vc_responsive

Blog

  Sanner and Amiko partner to develop digital solutions for true medication adherence Bensheim/Germany, London/UK, 13 February 2018 – How can artificial intelligence, drug delivery systems and add-ons help to improve true medication adherence? By combining long-standing experience in custom-made pharmaceutical packaging, dosing and delivery systems with advanced...

Amiko receives CE mark for use of the Respiro Platform with Teva’s Spiromax® Inhaler, Chiesi's Nexthaler® inhaler and GlaxoSmithKline's Ellipta® inhaler London, UK. Feb. 5, 2018 — Amiko Digital Health Limited (Amiko), a company that develops advanced medication sensor technologies and AI-powered digital health tools, announced today that...

MILANO, ITALY Job Summary We are looking for a young and passionate UX/UI intern to join our team (and perhaps a long-term position in the future), to design customer experience designs for new services solutions. We want someone who understands users, who can think differently and solve...

Amiko Digital Health announces the investment from strategic investors Sanner and Breed Reply London, UK. Dec. 18, 2017 — Amiko Digital Health Limited (Amiko), a company that develops advanced medication sensor technologies and AI-powered digital health tools, today announced the closing of a new financing round,...

  Amiko’s Respiro awarded with the 1st prize at the IBM Watson AI XPRIZE’s annual Milestone Awards Los Angeles, US. Dec. 8, 2017 — Amiko Digital Health Limited (Amiko), provider of advanced medication sensor technologies and AI-powered digital health tools, announced that the company has been recognized...